Cintas Stock Sinks on Drop in Uniform Direct Sales
Cintas shares tumbled Thursday as the provider of uniforms and other business supplies reported a decline in direct sales of its uniforms and warned about pricing.
Cintas shares tumbled Thursday as the provider of uniforms and other business supplies reported a decline in direct sales of its uniforms and warned about pricing.
The year ahead promises to be interesting for investors. We explore what experts say about the competing dynamics in 2025 and their impact on different areas of the stock market.
New research shows that the resale sector is accelerating fast, and has overtaken sales in the broader apparel, accessories and footwear categories.
Soho House’s billionaire chairman has revived efforts to take the private members’ club off the US stock market, backing a near $1.8bn (£1.4bn) buyout bid.
On Thursday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the lower back and hip that radiates down the back of the thigh into the leg. The study met its primary endpoint with a statistically significant and clinically meaningful reduction in pain on the numeric pain rating scale (NPRS). The suzetrigine arm showed a statistically significant and clinically mean
Micron Technology shares tanked Thursday after the chipmaker warned about near-term demand issues.
Vertex said the Phase II trial met its primary endpoint, however there was only a minor difference to placebo.
Major U.S. indexes rallied at midday Thursday, rebounding from Wednesday's selloff as a report showed the U.S. economy expanded more than anticipated in the third quarter.
The U.S. stock market experienced a severe selloff Wednesday after Federal Reserve Chair Jerome Powell‘s comments triggered what CNBC’s Jim Cramer described as “incredible panic” in the markets. What Happened: “People throwing away good and bad. Typical index fund behavior,” Cramer wrote on X, specifically highlighting concerns about small-cap stocks’ performance. “And all of those people who loved the Small Caps (the Russell 2000?) now what??” Don’t Miss: Warren Buffett once said, "If you don't
If markets hope to recover from the sharp sell-off triggered by the Federal Reserve’s December meeting, Friday's release of the Personal Consumption Expenditure price index — widely regarded as the Fed’s preferred inflation measure — will play a crucial role. Unfortunately for investors, the outlook is far from reassuring. Scheduled for release at 8:30 a.m. ET Friday, economists expect the PCE price index to climb to 2.5% year-over-year in November 2024, up from 2.3% in October. This would mark